From Mirels to Artificial Intelligence: Evolution of Fracture Risk Prediction in Metastatic Bone Disease and the Proposal of an Integrated Mirels 2.0 Framework
AI · 10.11.2026 · 7 (11) · 473
DOI: 10.3390/ai7110473 ↗Kurz gefasst
Fachartikel in der Zeitschrift AI, online erschienen am 10.11.2026. Verfasst von Florina Popa und 6 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Impending pathological fractures remain among the most challenging complications of metastatic bone disease. Accurate fracture-risk assessment is essential for selecting patients for prophylactic stabilization while avoiding unnecessary surgery. The Mirels Classification remains widely used, but limited specificity, observer variability, and site-dependent performance have stimulated interest in cortical-involvement measures, CT-based structural rigidity analysis (CTRA), finite element analysis (FEA), multivariable prediction, radiomics, and artificial intelligence (AI).
Methods
This narrative critical review synthesizes clinical, imaging, biomechanical, and computational evidence relevant to appendicular metastatic-fracture prediction. The literature search was updated through 22 October 2026, with direct metastatic-bone evidence prioritized and study design, anatomical site, sample size, prediction horizon, diagnostic performance, validation status, and major methodological limitations appraised qualitatively.
Results
Mirels performance varied substantially by site. In upper-limb disease, the conventional threshold of ≥9 showed 14% sensitivity in one cohort, whereas a humerus-specific cohort reported 83.6% sensitivity, 79.5% specificity, and an AUC of 0.82 at a threshold of ≥8. A 2026 systematic review found Mirels sensitivities of 66.7–88% and specificities of 38–47.9% in femoral studies; the principal prospective CTRA comparison reported 100% sensitivity and 60.6% specificity, while formal FEA studies reported sensitivities of 80–100% and specificities of 67–86%, with important methodological heterogeneity. A 2026 Met FRAP cohort of 565 lesions reported 82% accuracy for 6-month fracture prediction versus 61% for Mirels. No externally validated AI/radiomics model directly predicting appendicular metastatic long-bone fracture was identified.
Conclusions
Current evidence supports Mirels as an accessible first-layer screen rather than a stand-alone surgical indication. Integrated Mirels 2.0 is proposed as a conceptual, site-aware research framework that combines clinical assessment, quantitative imaging, biomechanics, tumor biology, patient factors, and optional AI integration with explicit uncertainty and prospective validation requirements.
Zitieren
APA
Popa, F., Adam, R., Manole-Pãlivan, C., Chiscop, I., Stãnescu, C., Moldovan, A., & Moldovan, C. (2026). From Mirels to Artificial Intelligence: Evolution of Fracture Risk Prediction in Metastatic Bone Disease and the Proposal of an Integrated Mirels 2.0 Framework. AI, 7(11), 473. https://doi.org/10.3390/ai7110473
Vancouver
Popa F, Adam R, Manole-Pãlivan C, Chiscop I, Stãnescu C, Moldovan A, et al. From Mirels to Artificial Intelligence: Evolution of Fracture Risk Prediction in Metastatic Bone Disease and the Proposal of an Integrated Mirels 2.0 Framework. AI. 2026;7(11):473. doi:10.3390/ai7110473
BibTeX
@article{Popa2026,
author = {Popa, Florina and Adam, Rãzvan and Manole-Pãlivan, Corina-Cecilia and Chiscop, Iulia and Stãnescu, Cristina and Moldovan, Adina-Diana and Moldovan, Cosmin-Alec},
title = {From Mirels to Artificial Intelligence: Evolution of Fracture Risk Prediction in Metastatic Bone Disease and the Proposal of an Integrated Mirels 2.0 Framework},
journal = {AI},
year = {2026},
volume = {7},
number = {11},
pages = {473},
doi = {10.3390/ai7110473}
}
EUVIMED